Long-Term Effectiveness of Quadruple Combination Therapy with Empagliflozin Versus Basal Long-Acting Insulin Therapy in Patients with Type 2 Diabetes: 3-Year Retrospective Observational Study

ConclusionEmpagliflozin was shown to perform as well as better than insulin when used as part of a quadruple drug regimen for regulating blood glucose levels in suboptimally controlled patients  with T2D.Clinical Trial NumberNCT 05103306 (ClinicalTrials.gov).
Source: Diabetes Therapy - Category: Endocrinology Source Type: research